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Purpose: Although the analgesic effects of corticosteroids have been well docu-
mented, little information is available on periarticular injection (PI) containing cor-
ticosteroids for early postoperative pain management after total knee arthroplasty 
(TKA). We performed a prospective double-blind randomized trial to evaluate the 
efficacy and safety of an intraoperative corticosteroid PI in patients undergoing 
TKA. Materials and Methods: Seventy-six consecutive female patients undergo-
ing bilateral staged TKA were randomized to receive steroid or non-steroid PI, 
with 3 months separating the procedures. The steroid group received PI with a 
mixture containing triamcinolone acetonide (40 mg). The non-steroid group re-
ceived the same injection mixture without corticosteroid. During the postoperative 
period, nighttime pain, functional recovery [straight leg raising (SLR) ability and 
maximal flexion], patient satisfaction, and complications were recorded. Short-
term postoperative clinical scores and patient satisfaction were evaluated at 6 
months. Results: The pain level was significantly lower in the PI steroid than the 
non-steroid group on the night of the operation (VAS, 1.2 vs. 2.3; p=0.021). Re-
bound pain was observed in both groups at POD1 (VAS, 3.2 vs. 3.8; p=0.248), but 
pain remained at a low level thereafter. No significant differences were seen in 
maximal flexion, frequency of acute rescuer, clinical scores, and patient satisfac-
tion. The steroid group was able to perform SLR earlier than the non-steroid group 
(p=0.013). The incidence of complications was similar between the groups. Con-
clusion: PI containing a corticosteroid provided an additional pain-relieving effect 
on the night of the operation. In addition, corticosteroid PI did not increase the 
perioperative complications of TKA.
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INTRODUCTION
Total knee arthroplasty (TKA) has been reported to be the most effective proce-
dure for pain relief in patients with advanced osteoarthritis. Ironically, however, 
many patients are concerned of immediate postoperative pain, preoperatively and 
actually experience considerable pain after surgery.1,2 Multimodal and pre-emptive 
approaches are currently used for perioperative pain relief. Periarticular injection 
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treatment of primary advanced osteoarthritis. Of the 90 eli-
gible patients, 8 were not enrolled because of refusal to par-
ticipate (n=5), major depressive disorder (n=1), and other 
diagnostic reasons (n=2) (Fig. 1). Thus, 82 patients were re-
cruited, and one knee was randomly assigned to the steroid 
or non-steroid PI group. After 3 months, the contralateral 
knee was assigned to the opposite group. The steroid group 
received a PI containing corticosteroid (40 mg of triamcin-
olone acetonide), and the non-steroid group received a PI 
without corticosteroid. Randomization was performed using 
a computer-generated permutation table of 4 and 6 blocks. 
Six of the 82 patients were excluded because of transfer due 
to congestive heart failure (n=1), transfer due to gastrointes-
tinal bleeding (n=1), delirium after surgery (n=1), and 
failed spinal anesthesia (n=3). Thus, 76 female patients 
were included in the final analysis (Fig. 1). The patients and 
an independent investigator who prospectively collected 
the clinical information were unaware of the group assign-
ments until the final data analysis was completed. There 
were all female patients with 69.3 years (mean age, ranging 
from 62 to 77). The median body mass index was 25.9 kg/
m2 (range, 22-32). The study protocol was approved by our 
Institutional Review Board and registered at Clinical Trials. 
All patients received the same spinal anesthetic and multi-
modal protocol to improve pain relief. Oral analgesic pills 
(200 mg celecoxib, 362.5 mg ultracet, and 75 mg pregabalin) 
were administered for preemptive analgesia on the morning 
of the operation. Spinal anesthesia, using 0.5% bupivacaine, 
was administered by an anesthesiologist; throughout sur-
gery, anesthesia was maintained with propofol using a tar-
get-controlled device.
All surgeries were performed before noon by a single 
surgeon (S.K.K) using a standard medial parapatellar ar-
throtomy with a tourniquet. A posteriorly stabilized pros-
thesis (PFC sigma; DePuy, Johnson & Johnson, Warsaw, 
USA) was implanted in all patients. The patella was unre-
surfaced in all cases, and cement fixation was used for all 
components. 
A multimodal PI cocktail (100 mL) consisting of 10 mg 
morphine sulfate, 300 mg ropivacaine, 30 mg ketorolac, 
300 μg of 1:1000 epinephrine, normal saline, and with or 
without a corticosteroid (40 mg of triamcinolone acetonide) 
was prepared in two 50-mL syringes. Before the implants 
were fixed with cement, 50 mL of the cocktail were injected 
into the posterior capsule, sheath of the medial and lateral 
collateral ligaments, and soft tissue above the medial and 
lateral femoral epicondyle. After insertion of polyethylene 
(PI) of a drug cocktail has been particularly effective in de-
creasing pain and improving early function after TKA.3-11 
However, there is no gold standard protocol regarding the 
drug composition and amount for the cocktail injection.
The mainstays of multimodal therapeutic approaches, in-
cluding drug cocktails, have been opioids.8,12 However, the 
effectiveness of opioids is limited by side effects such as re-
spiratory depression, urinary retention, nausea, and vomit-
ing.12 The use of systemic corticosteroids in a multimodal 
analgesic protocol is documented to be efficacious in the 
treatment of postoperative pain, nausea, and vomiting.12-14 
In contrast, there is little information on the role of cortico-
steroid in PI treatment for early postoperative pain manage-
ment. Previous studies that used a PI drug cocktail, with or 
without a corticosteroid, have documented pain relief and 
functional recovery, but did not examine the effect of the 
corticosteroid.3-5,7-11 
Therefore, we performed a prospective, randomized, dou-
ble-blind study to determine 1) whether a PI containing a 
corticosteroid provides an additional pain relief and func-
tional recovery effect and; 2) whether a PI containing a cor-
ticosteroid increases perioperative complications after TKA.
MATERIALS AND METHODS
　　　
Ninety female patients scheduled for bilateral TKAs pro-
vided informed consent to participate in this prospective, 
double-blinded study conducted from March 2010 to De-
cember 2011. Eligible patients included 90 female patients 
between the ages of 50 and 90 years who were scheduled to 
undergo staged bilateral TKA (3-month interval) for the 
Fig. 1. Subject screening flowchart. PI, periarticular injection; CHF, conges-
tive heart failure; GI, gastrointestinal; TKA, total knee arthroplasty.
Not enrolled (n=8)
-Refused to participate (n=5)
-Major depression (n=1)
-Reumatoid arthritis (n=2)
Excluded (n=6)
-Transfer d/t CHF (1)
-Transfer d/t GI bleeding (1)
-Delirium (1)
-Failed spinal anesthesia (3)
Assessed for eligibility (n=90)
Randomized (n=82)
Staged bilateral TKA
Steroid PI vs. non-steroid PI 
Included for analysis (n=76)
Steroid PI (76) vs. non-steroid PI (76)
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ences in categorical variables (frequency of acute rescuer 
and incidence of wound complications). Continuous vari-
ables (pain, functional recovery, clinical score, and patient 
satisfaction) were analyzed using Student’s t-test. An a pri-
ori power analysis using a 2-sided hypothesis test, at an al-
pha level of 0.05 and a power of 80%, was used to deter-
mine the sample size statistical power. One hundred-twenty 
knees were required to detect a difference of 1 in the VAS 
pain level, which we considered as clinically significant. 
Accordingly, the study sample size (152 knees) had suffi-
cient power to detect a difference.
RESULTS
 
The pain level was significantly lower in steroid-treated 
knees compared to non-steroid treated knees on the night of 
the operation (VAS, 1.2 vs. 2.3; p=0.021). Interestingly, re-
bound pain was observed in both groups 1 day after the sur-
gery (VAS, 3.2 vs. 3.8; p=0.248). Thereafter, pain remained 
at a low level and was not different between the 2 groups. 
In addition, the level of patient satisfaction decreased from 
the night of operation to the night of POD1 in both the ste-
roid PI (VAS, 9.0 to 7.8) and non-steroid PI groups (VAS, 
8.8 to 8.0) (Fig. 2). 
There were no significant differences in the secondary 
variables, including hemovac drainage, maximal flexion 
(postoperative day 7), and frequency of acute rescuer (post-
operative day 2). The steroid PI group was able to perform 
SLR earlier than the non-steroid PI group (p=0.013) (Table 
1). The 2 groups demonstrated similar postoperative range 
of motion, AKS score, WOMAC score, and patient satis-
faction at 6 months after TKA. 
The addition of corticosteroid did not increase the risk for 
wound complications, including infection or narcotic-relat-
ed side effects, during the immediate postoperative period 
(Table 2). 
DISCUSSION
The analgesic effects of corticosteroids have been well doc-
umented.12,14,15 However, little information is available on 
the role of corticosteroid PI in providing immediate postop-
erative pain relief and functional recovery after TKA. The 
most important finding of the current prospective study is 
that a PI containing a corticosteroid provided an additional 
bearings, a second 50 mL were injected into the peri-pes an-
serinus, capsule, quadriceps, subcutaneous tissue, and peri-
patella aponeurosis.
All patients received postoperative intravenous patient-
controlled analgesia (PCA), which was programmed to pro-
vide a continuous infusion of 500 μg fentanyl and 30 mL of 
0.5% bupivacaine, at a rate of 4 mL/h, with an on-demand 
bolus infusion of 2 mL with a 10-min lockout period. When 
patients resumed oral analgesic intake, 200 mg celecoxib 
and 362.5 mg ultracet were administered every 12 hours. An 
intramuscular injection of ketoprofen (100 mg) was used as 
an acute rescuer when a patient reported severe pain greater 
than 7 on a 0 to 10 Visual Analog Scale (VAS). The contin-
uous intravenous PCA was typically discontinued on the 
third postoperative day. The patient knees were placed daily 
in a continuous-passive-motion machine starting at 2 days 
after the operation until discharge. All patients were dis-
charged on postoperative day 9.
A clinical investigator who was blinded to the group as-
signments reviewed the diagnosis and medical histories, and 
prospectively collected the demographic data. Preoperative 
clinical status was evaluated using the knee motion arc, 
American Knee Society (AKS) knee and function scores, 
and Western Ontario and McMaster Universities Osteoarthri-
tis Index (WOMAC) scores. Postoperative clinical evalua-
tion was performed at 6 months using the same scales. Flex-
ion contracture and maximum flexion were measured to the 
nearest 5° by an investigator using a standard clinical goni-
ometer with the patients in a supine position.
The primary outcome variable was the postoperative night-
time pain levels on the night of the surgery and at postoper-
ative days 1, 2, 3, and 7. The pain levels were recorded by a 
clinical investigator using a VAS that ranged from 0 (no 
pain) to 10 (worst imaginable pain) at each time point. The 
secondary outcome variables were functional recovery 
[ability for straight leg raising (SLR) and maximal flexion], 
patient satisfaction, and complications. The level of patient 
satisfaction was obtained using a VAS on the operation night 
and postoperatively on days 1 and 7, as well as at 6 months. 
Wound complications, including periprosthetic joint infec-
tion, wound oozing, and wound dehiscence, were evaluat-
ed. In addition, patients were observed for narcotic-related 
side effects, including nausea, vomiting, respiratory depres-
sion, and urinary retention.
Statistical analyses were conducted using SPSS for Win-
dows Version 15 (SPSS Inc., Chicago, IL, USA). Chi-squared 
test or Fisher’s exact test was used to determine the differ-
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non-PI group.3-9 The current findings support these earlier 
observations by demonstrating that a PI with a corticosteroid 
provides additional pain relief on the night of the operation. 
However, our findings are in contrast to those of another 
study that compared PIs with and without a corticosteroid 
and found no effect of the corticosteroid on pain relief and 
functional recovery.10 Importantly, the above study assessed 
patient pain levels only 1 day after surgery and on the day 
of discharge. We found that an additional pain-relieving ef-
pain-relieving effect on the night of the operation but did 
not influence pain levels for the remainder of the postopera-
tive period. This study also confirms the safety of a PI con-
taining a corticosteroid for use in a multimodal analgesic 
protocol.
In previous studies of PI, some PI cocktails contained a 
corticosteroid whereas others did not. Irrespective of corti-
costeroid use, studies have documented an improvement in 
pain relief and functional recovery with PI, compared to a 
Table 1. Comparison of Patient Results
Parameter Steroid PI (n=76) Non-steroid PI (n=76) p value
Hemovac (cc)   458.4±156.1     491.8±182.1 0.482
SLR (POD)     2.26±0.903       2.88±0.833   0.013*
Maximal flexion at POD7 (degrees) 106.2±10.2 105.2±8.9 0.687
Acute rescuer to POD2 (frequency of i.m.)   1.7±0.7     1.8±1.0 0.759
PI, periarticular injection; SLR, straight leg raising; POD2, and POD7, 2 and 7 days postoperatively; i. m., intra-muscular injection.
*Indicates significance (p<0.05; 95% confidence intervals). 
Table 2. Comparison of Postoperative Clinical Outcomes and Complications 
Parameter Steroid PI Non-steroid PI p value
Postoperative (6 months)
    ROM (degrees) 131.1±10.7 128.3±12.5 0.509
    AKS knee 93.6±4.7 93.0±2.5 0.809
    AKS function   68.0±16.4   74.0±18.1 0.599
    WOMAC pain   1.8±2.1   1.4±2.6 0.799
    WOMAC function 19.6±8.5 20.8±9.3 0.838
    Satisfaction (POD7)   8.2±1.8   8.5±1.9 0.675
    Satisfaction (6 months)   9.0±1.9   8.7±1.7 0.722
Complications (%)
    Infection 0 0
    Wound oozing    8.3    6.5 0.294
    Nausea/vomiting  16.6  18.6 0.320
    Urinary retention 0 0
ROM, range of motion; AKS, American knee society; WOMAC, Western Ontario MacMaster Universities Osteoarthritis Index; POD7, 7 days postopera-
tively; PI, periarticular injection.
Fig. 2. Summary of nighttime pain levels (bar graph) and patient satisfaction (line graph). OP night, operation night; POD1, 2, 3, and 7; 1, 2, 3, and 7 days post-
operatively. *Indicates significance (p<0.05; 95% confidence intervals). VAS, Visual Analog Scale.
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corticosteroid on the night of the operation may be mean-
ingless.
This study also suggests that a PI with corticosteroid par-
tially improves functional recovery. The steroid PI group was 
able to perform SLR earlier than the non-steroid PI group, 
but maximal flexion was same between groups. This find-
ing concurs with that of a PI study by Koh, et al.,4 but most 
previous studies have reported that PI does not improve 
functional recovery.3,5,7-10 
Several studies have reported that intra-articular cortico-
steroid injection might increase the risk of joint complica-
tions.16,17 However, Sauerland, et al.15 found no adverse effects 
in patients who were treated perioperatively with methylpred-
nisolone during major surgery. In line with this, several other 
studies focused on PI also reported no increase in the risk of 
postoperative complications after corticosteroid PI.7,8,10 Our 
study also supports the notion that corticosteroid PI does not 
increase perioperative complications after TKA. There were 
no incidences of infection; minimal wound oozing was ob-
served but was not different between groups. 
Our study has several limitations. First, this study assessed 
bilateral staged TKA, with the surgeries separated by 3 
months. According to the gate-control theory,18 if one side 
has a severe pain level after surgery, the other side might feel 
a reduced pain level in bilateral simultaneous TKA. Thus, 
our study conducted bilateral staged surgery instead of bilat-
eral simultaneous surgery. However, a distorted pain level 
may be experienced after the second operation (3 months lat-
er) due to recall of previous pain from the first operation. 
Second, our study participants were all Korean women, 
therefore, our findings may not be generalized to other pa-
tient populations other than elderly females (mean age, 69.3 
years). However, since culture, gender, and age can influ-
ence the subjective perception of pain, we believe that our 
population findings are relevant. Finally, a single clinical in-
fect of corticosteroid PI appeared only on the night of the 
operation; therefore, this previous work might have failed 
to examine the critical period. In addition to a beneficial ef-
fect early after surgery, PI with triamcinolone also appeared 
to have a improved pain-relieving effect on postoperative 
days 1-7, as the steroid PI group demonstrated a lower, albe-
it non-significant, overall pain level during this period com-
pared to the non-steroid PI group (Fig. 2). The half-life of 
triamcinolone ranges from 18 to 36 hours, and intramuscu-
lar administration of this acetate form provides slow absorp-
tion but a prolonged duration.12 Patient pain is maximized 
at night because of minimal environmental stimuli, there-
fore, we focused on nighttime pain for the duration of our 
study. Overall, our findings are noteworthy, considering a 
multimodal PI protocol for postoperatively practical pain 
management.
One interesting finding was that rebound pain was ob-
served in both groups 1 day after surgery (night-time), and 
that the increase in pain was higher in the steroid PI group 
(+2.0) than in the non-steroid group (+1.5). When compar-
ing our study with previous PI works, we found that re-
bound pain level (amount of change) was the highest on 1 
day after surgery (Table 3). In the studies of Lombardi, et 
al.5 and Vendittoli, et al.9 there was no rebound pain on 
POD1. Their cocktail components were different from those 
used by recent studies, which included no morphine and 
low-dose local anesthetic. Recent studies of Busch, et al.,3 
Koh, et al.,4 and Mullaji, et al.6 observed rebound pain on 
POD1. Their cocktail components including drug composi-
tion and amount were similar to ours. Although the VAS 
pain scores increased by 1-2 point on POD1, we are not cer-
tain of it’s clinical significance. Importantly, rebound pain 
might directly influence patient satisfaction negatively (Fig. 
1). Thus, if a multimodal analgesic protocol cannot de-
crease rebound pain, an additional pain-relieving effect of 
Table 3. Comparison of Rebound Pain Level (VAS) between the Current and Previous Studies from the Night of Operation Un-
til Postoperative Day 1
Studies
Non-PI Steroid (-) PI Steroid (+) PI
POD0 POD1 Change* POD0 POD1 Change POD0 POD1 Change
Lombardi, et al.5 1.9 2.2 +0.3 3.4 2.7  -0.7
Vendittoli, et al.9 4.8 3.0  -1.8 2.5 2.0  -0.5
Busch, et al.3 5.6 5.2  -0.4 3.6 4.5 +0.9
Koh, et al.4 6.6 7.5 +0.9 3.5  4.6 +1.1
Mullaji, et al.6 5.0 6.3 +1.3 2.3 3.3 +1.0
Current study 2.3 3.8 +1.5 1.2 3.2 +2.0
POD0, and 1, 0 and 1 day postoperatively; PI, periarticular injection; VAS, Visual Analog Scale.
*Change=Pain VAS at POD1-Pain VAS at POD0. 
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rine, and morphine has a beneficial effect after total knee arthro-
plasty. Clin Orthop Relat Res 2004:125-30.
6. Mullaji A, Kanna R, Shetty GM, Chavda V, Singh DP. Efficacy of 
periarticular injection of bupivacaine, fentanyl, and methylpred-
nisolone in total knee arthroplasty: a prospective, randomized trial. 
J Arthroplasty 2010;25:851-7. 
7. Parvataneni HK, Shah VP, Howard H, Cole N, Ranawat AS, 
Ranawat CS. Controlling pain after total hip and knee arthroplasty 
using a multimodal protocol with local periarticular injections: a 
prospective randomized study. J Arthroplasty 2007;22(6 Suppl 
2):33-8.
8. Ranawat AS, Ranawat CS. Pain management and accelerated re-
habilitation for total hip and total knee arthroplasty. J Arthroplasty 
2007;22(7 Suppl 3):12-5.
9. Vendittoli PA, Makinen P, Drolet P, Lavigne M, Fallaha M, 
Guertin MC, et al. A multimodal analgesia protocol for total knee 
arthroplasty. A randomized, controlled study. J Bone Joint Surg 
Am 2006;88:282-9.
10. Christensen CP, Jacobs CA, Jennings HR. Effect of periarticular 
corticosteroid injections during total knee arthroplasty. A double-
blind randomized trial. J Bone Joint Surg Am 2009;91:2550-5. 
11. Han CD, Lee DH, Yang IH. Intra-synovial ropivacaine and mor-
phine for pain relief after total knee arthroplasty: a prospective, 
randomized, double blind study. Yonsei Med J 2007;48:295-300.
12. Salerno A, Hermann R. Efficacy and safety of steroid use for post-
operative pain relief. Update and review of the medical literature. 
J Bone Joint Surg Am 2006;88:1361-72.
13. Gilron I. Corticosteroids in postoperative pain management: future 
research directions for a multifaceted therapy. Acta Anaesthesiol 
Scand 2004;48:1221-2.
14. Wang JJ, Ho ST, Lee SC, Tang JJ, Liaw WJ. Intraarticular triam-
cinolone acetonide for pain control after arthroscopic knee sur-
gery. Anesth Analg 1998;87:1113-6.
15. Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. 
Risks and benefits of preoperative high dose methylprednisolone in 
surgical patients: a systematic review. Drug Saf 2000;23:449-61.
16. Armstrong RW, Bolding F, Joseph R. Septic arthritis following ar-
throscopy: clinical syndromes and analysis of risk factors. Ar-
throscopy 1992;8:213-23.
17. Montgomery SC, Campbell J. Septic arthritis following arthrosco-
py and intra-articular steroids. J Bone Joint Surg Br 1989;71:540.
18. DeLeo JA. Basic science of pain. J Bone Joint Surg Am 2006;88 
Suppl 2:58-62.
vestigator assessed only nighttime pain level, which is 
thought to be a good method to use in pain studies. Even 
though all surgeries were conducted before noon, the timing 
of pain assessment after surgery differed between patients. 
Furthermore, some patients were asked to recall pain levels; 
therefore, recall bias and observer bias may be involved.
In conclusion, PI containing a corticosteroid provided an 
additional pain-relieving effect on the night of the opera-
tion, but not for the remainder of the postoperative period. 
Because of the rebound in the level of pain at postoperative 
day 1, the lower pain immediately after the surgery with 
steroid treatment does not guarantee sustained pain relief 
after TKA. Further studies focused on sustaining a low lev-
el of pain level, without rebound, during the postoperative 
period should be conducted. In addition, corticosteroid PI 
did not increase perioperative complications after TKA, 
which confirms the safety of PI containing corticosteroid 
for use in a multi-modal analgesic protocol.
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